Severe asthma phenotypes in patients controlled with omalizumab: A real-world study

The appropriate identification of asthma phenotypes of responders to omalizumab would optimize the selection of treatment.

Source: Respiratory Medicine - October 20, 2019 Category: Respiratory Medicine Authors: Paloma Campo Mozo, Jos é Gregorio Soto-Campos, Marina Blanco Aparicio, Ana Moreira Jorge, Héctor Manuel González Expósito, Santiago Quirce Gancedo, Ignacio Dávila González Source Type: research